BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34397495)

  • 1. Sulfasalazine-Induced Toxic Epidermal Necrolysis: A Challenging Case During the COVID-19 Pandemic.
    Shahidi-Dadras M; Shahrigharahkoshan S; Yazdi E; Fatemi A; Mahboubi-Fooladi Z; Dadkhahfar S
    Adv Emerg Nurs J; 2021 Jul-Sep 01; 43(3):194-197. PubMed ID: 34397495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.
    Tremblay L; Pineton de Chambrun G; De Vroey B; Lavogiez C; Delaporte E; Colombel JF; Cortot A
    J Crohns Colitis; 2011 Oct; 5(5):457-60. PubMed ID: 21939920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toxic epidermal necrolysis during therapy with sulphasalazine in a patient with arthritis. Case report].
    Rachwał-Siek K; Ponikowska M; Wiland P
    Wiad Lek; 2011; 64(4):283-7. PubMed ID: 22533153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal toxic epidermal necrolysis associated with hydroxychloroquine.
    Murphy M; Carmichael AJ
    Clin Exp Dermatol; 2001 Jul; 26(5):457-8. PubMed ID: 11488840
    [No Abstract]   [Full Text] [Related]  

  • 6. Photo-induced Stevens-Johnson syndrome due to sulfasalazine therapy.
    Borrás-Blasco J; Navarro-Ruiz A; Matarredona J; Devesa P; Montesinos-Ros A; González-Delgado M
    Ann Pharmacother; 2003 Sep; 37(9):1241-3. PubMed ID: 12921507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine-induced fatal toxic epidermal necrolysis complicated by angioinvasive rhizopus.
    Cameron MC; Word AP; Dominguez A
    Dermatol Online J; 2014 Nov; 20(11):. PubMed ID: 25419748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis.
    Ulubaş B; Sahin G; Ozer C; Aydin O; Ozgür E; Apaydin D
    Clin Rheumatol; 2004 Jun; 23(3):249-51. PubMed ID: 15168156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic epidermal necrolysis due to therapy with cyclophosphamide and mesna. A case report of a patient with seronegative rheumatoid arthritis and rheumatoid vasculitis.
    Chowdhury AC; Misra DP; Patro PS; Agarwal V
    Z Rheumatol; 2016 Mar; 75(2):200-2. PubMed ID: 26555550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic Epidermal Necrolysis in a Pediatric Patient.
    Hagen S; Grey K; Hylwa S
    Minn Med; 2016; 99(3):49-50. PubMed ID: 27323526
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 infection increases the development of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort analysis.
    Curtis KK; Dillan MM; Sharma TR; Piktel J
    J Am Acad Dermatol; 2024 Jun; 90(6):1300-1302. PubMed ID: 38423469
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of toxic epidermal necrolysis secondary to indomethacin.
    O'Sullivan M; Hanly JG; Molloy M
    Br J Rheumatol; 1983 Feb; 22(1):47-9. PubMed ID: 6824826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant cell myocarditis in a patient with a spondyloarthropathy after a drug hypersensitivity reaction.
    Mitoff PR; Mesana TG; Mielniczuk LM; Grenon J; Veinot JP; Cooper LT; Davies RA
    Can J Cardiol; 2013 Sep; 29(9):1138.e7-8. PubMed ID: 23474137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfasalazine induced lichen planus in a patient of rheumatoid arthritis.
    Ghosh S; Jain VK; Chaudhuri S; Mathur SK
    Indian J Dermatol Venereol Leprol; 2013; 79(4):541-4. PubMed ID: 23760333
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-dependent binding of circulating antibodies in drug-induced toxic epidermal necrolysis.
    Hensen EJ; Claas FH; Vermeer BJ
    Lancet; 1981 Jul; 2(8238):151-2. PubMed ID: 6113511
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulphasalazine.
    Maddocks JL; Slater DN
    J R Soc Med; 1980 Aug; 73(8):587-8. PubMed ID: 6112274
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythroderma and toxic epidermal necrolysis caused by to 5-aminosalacylic acid.
    Iemoli E; Piconi S; Ardizzone S; Bianchi Porro G; Raimond F
    Inflamm Bowel Dis; 2006 Oct; 12(10):1007-8. PubMed ID: 17012974
    [No Abstract]   [Full Text] [Related]  

  • 18. A Rare Case Report of Toxic Epidermal Necrolysis Due to Ofloxacin.
    Vaghela JJ; Nimbark VN; Chavda BC; Mehta HH; Purohit BM
    Curr Drug Saf; 2018; 13(2):137-140. PubMed ID: 29506464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DRESS syndrome induced by sulphasalazine in rheumatoid arthritis.
    Bejia I; Ben Hammouda S; Riahi K; Zinelabidine F; Mediouni B; Touzi M; Bergaoui N
    Joint Bone Spine; 2006 Dec; 73(6):764-5. PubMed ID: 16626997
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.